Retrospective Study
Copyright ©The Author(s) 2018.
World J Crit Care Med. Nov 30, 2018; 7(6): 73-83
Published online Nov 30, 2018. doi: 10.5492/wjccm.v7.i6.73
Table 1 Descriptive statistics of 16 intensive care unit patients with hemophagocytic Lymphohistiocytosis [expressed as median (IQR)] n (%)
ParameterValue
Age (yr)49 (26-61)
Sex
Male10 (63)
Female6 (37)
SOFA score on ICU admission10 (7-15)
Time from hospital to ICU admission0.5 (0-7)
Time to diagnose HLH (d)3 (1-7)
Immunodeficiency11 (69)
HIV infection2
Malignancy7
Autoimmune (SLE, autoimmune hemolytic anemia)2
Precipitating factors
Infection only5 (31)
Pneumonia2
EBV2
Typhoid fever1
Malignancy only2 (13)
Diffuse large B cell lymphoma1
T cell lymphoma1
Infection and malignancy combined5 (31)
EBV and plasmablastic lymphoma1
EBV and Hodgkin lymphoma1
EBV and diffuse large B cell lymphoma1
EBV and NK cell leukemia1
EBV associated lymphoproliferative disorder1
Idiopathic4 (25)
Number of HLH criteria met5 (5-6)
Principal reason for ICU admission
Severe sepsis/septic shock9 (56)
Acute respiratory failure4 (25)
GI Bleed2 (13)
Acute encephalopathy1 (6)
ICU length of stay (d)11.5 (5-29)
Hospital length of stay (d)29 (17-40)
Prior history of HLH3 (19)
Biopsies performed23
Bone marrow13
Liver4
Lymph node3
Skin2
Lung1
Bi/pancytopenia on ICU admission10 (63)
Hemophagocytosis seen on bone marrow biopsy (out of total)10 (77)
Chemotherapy received15 (94)